People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EvolveImmune Therapeutics Holding Company, LLC | — | Biotechnology | Series B | $85.8M | $124.9M | 2024 |
Donmienne Leung at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Donmienne Leung on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen Bloch | 1 | 15 |
| Derek Yoon | 1 | 4 |
| Ian Taylor | 1 | 3 |
| Hugo Beekman | 1 | 2 |
| Jasmina Marjanovic | 1 | 1 |
| Denis Patrick | 1 | 1 |
| Alessandra Di Bacco | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.